Share of S. aureus infections resistant to methicillin in Philippines

Philippines: Share of S. aureus infections resistant to methicillin was 44.4% in 2022. ▼ Falling

Latest (2022)
44.4%
Change on year
down 0.4%
World rank
13th
of 45 countries
All-time high
66.1%
in 2016
All-time low
44.4%
in 2022
Years of data
7
2016–2022

Share of S. aureus infections resistant to methicillin in Philippines, 2016–2022

02040602016201920222016: 66.1 %2017: 58.1 %2018: 55.4 %2019: 50.9 %2020: 45.7 %2021: 44.6 %2022: 44.4 %

Source: World Health Organization – processed by Our World in Data. Measured in %.

Analysis

In 2022, share of s. aureus infections resistant to methicillin in Philippines stood at 44.4%. That is the lowest value across all 7 years on record.

Compared with earlier readings it is down 0.4% on the previous year and down 32.8% over ten years.

That places Philippines 13th out of 45 countries with data for 2022, putting it in the middle of the range.

Share of S. aureus infections resistant to methicillin in Philippines, year by year

Annual values for Share of S. aureus infections resistant to methicillin in Philippines, 2016 to 2022.
Year % Change
2016 66.1%
2017 58.1% -12.1%
2018 55.4% -4.6%
2019 50.9% -8.2%
2020 45.7% -10.2%
2021 44.6% -2.4%
2022 44.4% -0.4%

Averages by decade

DecadeAverage LowestHighest Years
2010s 57.6% 50.9% 66.1% 4
2020s 44.9% 44.4% 45.7% 3

Countries ranked near Philippines

  1. 10 Lebanon 52.5% compare
  2. 11 Saudi Arabia 52.0% compare
  3. 12 Republic of Korea 45.7% compare
  4. 14 Greece 41.1% compare
  5. 15 United Arab Emirates 39.9% compare
  6. 16 Indonesia 35.2% compare

See the full ranking of 45 places →

More reference data data for Philippines

All data for Philippines →

Frequently asked questions

What is share of s. aureus infections resistant to methicillin in Philippines?
Share of s. aureus infections resistant to methicillin in Philippines was 44.4% in 2022, according to World Health Organization – processed by Our World in Data.
What is the highest share of s. aureus infections resistant to methicillin recorded in Philippines?
The highest recorded value was 66.1% in 2016.
What is the lowest share of s. aureus infections resistant to methicillin recorded in Philippines?
The lowest recorded value was 44.4% in 2022.
How does Philippines rank for share of s. aureus infections resistant to methicillin?
Philippines ranks 13th out of 45 countries with data for 2022.
Is share of s. aureus infections resistant to methicillin rising or falling in Philippines?
Over the last ten years it is down 32.8%. The long-run trend across the full record is falling.
Where does this Philippines data come from?
The figures come from World Health Organization – processed by Our World in Data, published as part of Share of S. aureus infections resistant to methicillin. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of S. aureus infections resistant to methicillin in Philippines. Statizoid, drawing on World Health Organization – processed by Our World in Data. Retrieved 31 August 2026, from https://reference.statizoid.com/stat/share-of-s-aureus-bloodstream-infections-that-are-resistant-to-antibiotics/philippines/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/share-of-s-aureus-bloodstream-infections-that-are-resistant-to-antibiotics/philippines/">Share of S. aureus infections resistant to methicillin in Philippines</a> — Statizoid

About this data

Indicator
Share of S. aureus infections resistant to methicillin
Unit
%
Source
World Health Organization – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
45 places, 273 data points, 2016–2022
Last refreshed

Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).